Discover and read the best of Twitter Threads about #NWBO
Most recents (4)
@annenbcnews
Hi Anne, my husband was dx w/ a #GBM in May 2022. I'm confused by how you did a GBM story w/o discussing the most significant development ever for brain tumors.
Please follow up with #UCLA & #NWBO #DCVAX. Completed P3 last May, approved for UK Specials already &
1/
Hi Anne, my husband was dx w/ a #GBM in May 2022. I'm confused by how you did a GBM story w/o discussing the most significant development ever for brain tumors.
Please follow up with #UCLA & #NWBO #DCVAX. Completed P3 last May, approved for UK Specials already &
1/
is a personalized, nontoxic vaccine. It has given patients w/ a 10-18 month prognosis 9, 12, 16, 20+ years & counting with no addtl treatment.
My husband is a 52 yo firefighter and we are counting on #DCVAX to save his life. He doesn't have time for the treatment you covered
2/
My husband is a 52 yo firefighter and we are counting on #DCVAX to save his life. He doesn't have time for the treatment you covered
2/
This vaccine was created in the US and UK will have full approval before the US, forcing US patients like @Clairotonin, a 36 yo ICU nurse who desperately needs it, to try to get to the UK at a cost of $300k
We need #DCVAX approved by @US_FDA for compassionate use ASAP and
3/
We need #DCVAX approved by @US_FDA for compassionate use ASAP and
3/
@BerkeleyJr
While I'm glad you covered #GBM tumors, you missed the headline. Instead of sharing the incredible successes of #NWBO #DCVAX and how many patients have gone 9, 12, 16, 21 years and counting w/ no addtl treatment, you focused on a Phase 2.
1/
While I'm glad you covered #GBM tumors, you missed the headline. Instead of sharing the incredible successes of #NWBO #DCVAX and how many patients have gone 9, 12, 16, 21 years and counting w/ no addtl treatment, you focused on a Phase 2.
1/
Phase 3 was presented last May. JAMA included in their journal and 60 top docs signed on. Plus the combo trial with Keytruda and Poly-ICLC is incredible.
#DCVAX is helping people NOW. It was created at UCLA and trials were conducted in the UK, CANADA, and GERMANY too.
2/
#DCVAX is helping people NOW. It was created at UCLA and trials were conducted in the UK, CANADA, and GERMANY too.
2/
#NWBO As a physician, there is several reasons why the idea of DCVax-L is exciting. #1. Patient compliance for medication in general is about 50-60%. The higher the side effect profile or burden of treatment, the lower the the compliance rate. DCVax-L immense advantage here.
You know who else hates side effects? Physicians. So when a treatment is given as an intradermal injection (high and known compliance) with such a low side effect profile, its something I am very excited about.
#2. After regulatory approval, you have to ask yourself, will neuro surgeons, neuro oncologist, oncologists be prescribing DCVax-L to their patients? Community physicians typically follow the lead of major academic institutions and thought leaders in their field. See prior post
#NWBO, Re-reading 2018 DCVax-L interim results and actually took the time to look at the authors and where they are all from.
Liau - UCLA
Ashkan - King College
Tran - University of Floria
Campian - Washington University
Trusheim - Abbott NW Hospital
Liau - UCLA
Ashkan - King College
Tran - University of Floria
Campian - Washington University
Trusheim - Abbott NW Hospital
Cobbs - Swedish Medical Center
Heth - University of Michigan
Salacz - University of Kansas Cancer Center
D’Andre - Sutter Institute
Iwamoto - Columbia University
Dropcho - Indiana University Simon Cancer Center
Moshel - Overlook Medical Center
Walter - University of Rochester
Heth - University of Michigan
Salacz - University of Kansas Cancer Center
D’Andre - Sutter Institute
Iwamoto - Columbia University
Dropcho - Indiana University Simon Cancer Center
Moshel - Overlook Medical Center
Walter - University of Rochester
Pillainayagam - Rush University Medical Center
Aiken - Rutgers Cancer Institute
Chaudhary - University of Cincinnati Medical Center
Goldlust - Hackensack University Medical Center
Bota - UC Irvine
Duic - Winthrop University
Grewal - NYU Winthrop
Elinzano - Rhode Island Hospital
Aiken - Rutgers Cancer Institute
Chaudhary - University of Cincinnati Medical Center
Goldlust - Hackensack University Medical Center
Bota - UC Irvine
Duic - Winthrop University
Grewal - NYU Winthrop
Elinzano - Rhode Island Hospital
